Jinfeng Ning

971 total citations
22 papers, 724 citations indexed

About

Jinfeng Ning is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jinfeng Ning has authored 22 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Jinfeng Ning's work include RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jinfeng Ning is often cited by papers focused on RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Jinfeng Ning collaborates with scholars based in China and United States. Jinfeng Ning's co-authors include Shidong Xu, Donghong Zhang, Dengying Wu, Lianpin Wu, Hai Xu, Shengfa Wang, Yaoguo Lang, Jinfeng Zhang, Kaibin Zhu and Fengjiao Wang and has published in prestigious journals such as Cell Death and Disease, Cells and BMC Cancer.

In The Last Decade

Jinfeng Ning

21 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinfeng Ning China 13 559 313 135 121 75 22 724
Hong Ren China 20 685 1.2× 504 1.6× 88 0.7× 223 1.8× 54 0.7× 49 959
Bei Sun China 13 283 0.5× 165 0.5× 62 0.5× 184 1.5× 78 1.0× 26 526
Kaifang Ma China 11 432 0.8× 323 1.0× 150 1.1× 87 0.7× 44 0.6× 28 614
Caifeng Yue China 9 305 0.5× 150 0.5× 51 0.4× 113 0.9× 29 0.4× 20 481
Zhonghua Ma China 15 736 1.3× 674 2.2× 54 0.4× 78 0.6× 57 0.8× 23 871
Yaojun Peng China 10 347 0.6× 199 0.6× 78 0.6× 158 1.3× 33 0.4× 24 586
Jiang Shi China 14 619 1.1× 446 1.4× 69 0.5× 75 0.6× 33 0.4× 25 753
Haiyun Xie China 20 953 1.7× 575 1.8× 101 0.7× 97 0.8× 90 1.2× 31 1.1k
Haiyun Zhao China 10 304 0.5× 154 0.5× 51 0.4× 103 0.9× 17 0.2× 13 423

Countries citing papers authored by Jinfeng Ning

Since Specialization
Citations

This map shows the geographic impact of Jinfeng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfeng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfeng Ning more than expected).

Fields of papers citing papers by Jinfeng Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfeng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfeng Ning. The network helps show where Jinfeng Ning may publish in the future.

Co-authorship network of co-authors of Jinfeng Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Jinfeng Ning. A scholar is included among the top collaborators of Jinfeng Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinfeng Ning. Jinfeng Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Shaoyan, Jinfeng Ning, Qingqing Wang, & Wei Wang. (2023). Fluorescence enhancement of flavonoids and its application in ingredient determination for some traditional Chinese medicines by CE-LIF. Analytical Methods. 15(24). 2964–2970. 4 indexed citations
4.
Ning, Jinfeng, et al.. (2022). Down-regulated m6A reader FTO destabilizes PHF1 that triggers enhanced stemness capacity and tumor progression in lung adenocarcinoma. Cell Death Discovery. 8(1). 354–354. 13 indexed citations
5.
Zhu, Kaibin, et al.. (2022). A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma. Frontiers in Genetics. 13. 891301–891301. 6 indexed citations
6.
Wang, Ping, et al.. (2022). Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors. Cell Death and Disease. 13(3). 216–216. 12 indexed citations
7.
Ning, Jinfeng, Imoh S. Okon, Xiaoxu Zheng, et al.. (2021). Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer. Cell Death and Disease. 12(6). 518–518. 41 indexed citations
8.
Bu, Jianlong, et al.. (2021). Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer: a single-center study in China. Journal of Cardiothoracic Surgery. 16(1). 304–304. 8 indexed citations
9.
Ning, Jinfeng, et al.. (2021). Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC. Frontiers in Genetics. 12. 779155–779155. 10 indexed citations
10.
Lou, Xiaoying, Jinfeng Ning, Kexin Li, et al.. (2021). YTHDF1 Promotes Cyclin B1 Translation through m6A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation. Cells. 10(7). 1669–1669. 24 indexed citations
11.
Wu, Lianpin, et al.. (2019). Changes of N6-methyladenosine modulators promote breast cancer progression. BMC Cancer. 19(1). 326–326. 126 indexed citations
12.
He, Changjun, Kaibin Zhu, Xue Bai, et al.. (2018). Placental Growth Factor Mediates Crosstalk Between Lung Cancer Cells and Tumor-Associated Macrophages in Controlling Cancer Vascularization and Growth. Cellular Physiology and Biochemistry. 47(6). 2534–2543. 16 indexed citations
13.
Wang, Fengjiao, Jinfeng Ning, Junfeng Wang, et al.. (2018). Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis. International Journal of Biological Sciences. 14(4). 406–417. 108 indexed citations
14.
Wang, Fengjiao, Gang� Li, Jinfeng Ning, et al.. (2018). Alcohol accumulation promotes esophagitis via pyroptosis activation. International Journal of Biological Sciences. 14(10). 1245–1255. 38 indexed citations
15.
Sun, Lixin, Yaoguo Lang, Jun Wu, et al.. (2016). Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer. BMC Cancer. 16(1). 449–449. 41 indexed citations
16.
Ning, Jinfeng, Chunhong Li, Jing Hu, et al.. (2015). Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer. Tumor Biology. 37(5). 6331–6336. 33 indexed citations
17.
Ning, Jinfeng, et al.. (2014). Ran GTPase Induces EMT and Enhances Invasion in Non-Small Cell Lung Cancer Cells Through Activation of PI3K-AKT Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 21(2). 67–72. 26 indexed citations
18.
Ning, Jinfeng, et al.. (2012). Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer. European Journal of Histochemistry. 56(4). 46–46. 40 indexed citations
19.
Zhang, Jinfeng, Jinfeng Ning, Jingshu Geng, Binbin Cui, & Xinshu Dong. (2012). Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer. Journal of Molecular Histology. 43(6). 715–721. 12 indexed citations
20.
Xu, Shidong, et al.. (2011). MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis. Medical Oncology. 29(3). 1673–1680. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026